Correlation Between Akari Therapeutics and Bio Path
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Bio Path Holdings, you can compare the effects of market volatilities on Akari Therapeutics and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Bio Path.
Diversification Opportunities for Akari Therapeutics and Bio Path
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Akari and Bio is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Bio Path go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Bio Path
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Bio Path. But the stock apears to be less risky and, when comparing its historical volatility, Akari Therapeutics PLC is 2.17 times less risky than Bio Path. The stock trades about -0.08 of its potential returns per unit of risk. The Bio Path Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 97.00 in Bio Path Holdings on November 2, 2024 and sell it today you would lose (15.00) from holding Bio Path Holdings or give up 15.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Bio Path Holdings
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Bio Path Holdings |
Akari Therapeutics and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Bio Path
The main advantage of trading using opposite Akari Therapeutics and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |